- Home
- CTNM vs DHY Comparison
CTNM vs DHY Comparison
Compare CTNM & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- DHY
- Stock Information
- Founded
- CTNM 2009
- DHY 1998
- Country
- CTNM United States
- DHY United States
- Employees
- CTNM N/A
- DHY N/A
- Industry
- CTNM
- DHY Finance/Investors Services
- Sector
- CTNM
- DHY Finance
- Exchange
- CTNM Nasdaq
- DHY Nasdaq
- Market Cap
- CTNM 248.7M
- DHY 213.4M
- IPO Year
- CTNM 2024
- DHY N/A
- Fundamental
- Price
- CTNM $12.16
- DHY $2.08
- Analyst Decision
- CTNM Strong Buy
- DHY
- Analyst Count
- CTNM 5
- DHY 0
- Target Price
- CTNM $22.20
- DHY N/A
- AVG Volume (30 Days)
- CTNM 194.4K
- DHY 569.1K
- Earning Date
- CTNM 11-05-2025
- DHY 01-01-0001
- Dividend Yield
- CTNM N/A
- DHY 9.10%
- EPS Growth
- CTNM N/A
- DHY N/A
- EPS
- CTNM N/A
- DHY N/A
- Revenue
- CTNM N/A
- DHY N/A
- Revenue This Year
- CTNM N/A
- DHY N/A
- Revenue Next Year
- CTNM N/A
- DHY N/A
- P/E Ratio
- CTNM N/A
- DHY N/A
- Revenue Growth
- CTNM N/A
- DHY N/A
- 52 Week Low
- CTNM $3.35
- DHY $1.77
- 52 Week High
- CTNM $20.24
- DHY $2.08
- Technical
- Relative Strength Index (RSI)
- CTNM 56.27
- DHY 46.81
- Support Level
- CTNM $10.65
- DHY $2.04
- Resistance Level
- CTNM $12.14
- DHY $2.13
- Average True Range (ATR)
- CTNM 0.92
- DHY 0.02
- MACD
- CTNM -0.21
- DHY -0.00
- Stochastic Oscillator
- CTNM 34.98
- DHY 50.00
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company to seeks high current income and capital appreciation as a secondary objective.